Laquinimod Sodium Salt
CAS : 248282-07-7
Ref. 3D-FL159548
| 1mg | Arrêté | ||
| 2mg | Arrêté | ||
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté |
Informations sur le produit
Nom :
Laquinimod Sodium Salt
Synonymes :
- N-Ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide sodium salt
- 3-Quinolinecarboxamide, 5-chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-, sodium salt (1:1)
- 3-Quinolinecarboxamide, 5-chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-, sodium salt
- Laquinimod sodium
- ABR 215062 sodium
Description :
Laquinimod is a quinoline derivative that is used as a pharmaceutical preparation. It has been shown to be a potent inhibitor of the cb1 receptor, which is responsible for the inflammatory response. Laquinimod also inhibits the phosphorylation of focal adhesion kinase (FAK) and prostaglandin E2 production in mice with colitis. The drug has been shown to have anti-inflammatory effects in several animal models of inflammatory diseases, such as collagen-induced arthritis, experimental autoimmune encephalomyelitis (EAE), or chronic granulomatous disease.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
378.78 g/mol
Formule :
C19H16ClN2NaO3
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
